Caicun Zhou

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 23

Top Topics

Squamous Cell Carcinoma

Small Cell Lung Cancer

Placebo Controlled

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal for immunotherapy of cancer

Therapeutic advances in medical oncology

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Maurice Pérol, Benjamin J Solomon, Koichi Goto, Keunchil Park, Ernest Nadal, Emilio Bria, Claudio Marcelo Martin, Jair Bar, Justin N Williams, Tarun Puri, Jian Li, Minji K Uh, Boris K Lin, Caicun Zhou
CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced Non-Small Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (21) (2024)
Shengxiang Ren, Xicheng Wang, Bao-Hui Han, Yueyin Pan, Jun Zhao, Yufeng Cheng, Sheng Hu, Tianshu Liu, Yalun Li, Ying Cheng, Jifeng Feng, Shanyong Yi, Shanzhi Gu, Shegan Gao, Yongzhong Luo, Ying Liu, Caigang Liu, Huijie Duan, Shuni Wang, Xinfeng Yang, Jia Fan, Caicun Zhou
First-line treatment with camrelizumab plus famitinib in advanced or metastatic NSCLC patients with PD-L1 TPS ≥1%: results from a multicenter, open-label, phase 2 trial. Journal for immunotherapy of cancer 12 (2) (2024)
Wei Li, Anwen Xiong, Nong Yang, Huijie Fan, Qitao Yu, Yanqiu Zhao, Yongsheng Wang, Xue Meng, Jingxun Wu, Ziping Wang, Yunpeng Liu, Xicheng Wang, Xintian Qin, Kaihua Lu, Wu Zhuang, Yizhong Ren, Xianyu Zhang, Bing Yan, Christine M Lovly, Caicun Zhou
Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non-Small Cell Lung Cancer: The Phase II TRUST-I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Shengxiang Ren, Xicheng Wang, Bao-Hui Han, Yueyin Pan, Jun Zhao, Yufeng Cheng, Sheng Hu, Tianshu Liu, Yalun Li, Ying Cheng, Jifeng Feng, Shanyong Yi, Shanzhi Gu, Shegan Gao, Yongzhong Luo, Ying Liu, Caigang Liu, Huijie Duan, Shuni Wang, Xinfeng Yang, Jia Fan, Caicun Zhou
First-line treatment with camrelizumab plus famitinib in advanced or metastatic NSCLC patients with PD-L1 TPS ≥1%: results from a multicenter, open-label, phase 2 trial. Journal for immunotherapy of cancer 12 (2) (2024)
Wei Li, Anwen Xiong, Nong Yang, Huijie Fan, Qitao Yu, Yanqiu Zhao, Yongsheng Wang, Xue Meng, Jingxun Wu, Ziping Wang, Yunpeng Liu, Xicheng Wang, Xintian Qin, Kaihua Lu, Wu Zhuang, Yizhong Ren, Xianyu Zhang, Bing Yan, Christine M Lovly, Caicun Zhou
Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non-Small Cell Lung Cancer: The Phase II TRUST-I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Wei Li, Anwen Xiong, Nong Yang, Huijie Fan, Qitao Yu, Yanqiu Zhao, Yongsheng Wang, Xue Meng, Jingxun Wu, Ziping Wang, Yunpeng Liu, Xicheng Wang, Xintian Qin, Kaihua Lu, Wu Zhuang, Yizhong Ren, Xianyu Zhang, Bing Yan, Christine M Lovly, Caicun Zhou
Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non-Small Cell Lung Cancer: The Phase II TRUST-I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Wei Li, Anwen Xiong, Nong Yang, Huijie Fan, Qitao Yu, Yanqiu Zhao, Yongsheng Wang, Xue Meng, Jingxun Wu, Ziping Wang, Yunpeng Liu, Xicheng Wang, Xintian Qin, Kaihua Lu, Wu Zhuang, Yizhong Ren, Xianyu Zhang, Bing Yan, Christine M Lovly, Caicun Zhou
Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non-Small Cell Lung Cancer: The Phase II TRUST-I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (22) (2024)
Shengxiang Ren, Xicheng Wang, Bao-Hui Han, Yueyin Pan, Jun Zhao, Yufeng Cheng, Sheng Hu, Tianshu Liu, Yalun Li, Ying Cheng, Jifeng Feng, Shanyong Yi, Shanzhi Gu, Shegan Gao, Yongzhong Luo, Ying Liu, Caigang Liu, Huijie Duan, Shuni Wang, Xinfeng Yang, Jia Fan, Caicun Zhou
First-line treatment with camrelizumab plus famitinib in advanced or metastatic NSCLC patients with PD-L1 TPS ≥1%: results from a multicenter, open-label, phase 2 trial. Journal for immunotherapy of cancer 12 (2) (2024)
Maurice Pérol, Benjamin J Solomon, Koichi Goto, Keunchil Park, Ernest Nadal, Emilio Bria, Claudio Marcelo Martin, Jair Bar, Justin N Williams, Tarun Puri, Jian Li, Minji K Uh, Boris K Lin, Caicun Zhou
CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced Non-Small Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (21) (2024)
Maurice Pérol, Benjamin J Solomon, Koichi Goto, Keunchil Park, Ernest Nadal, Emilio Bria, Claudio Marcelo Martin, Jair Bar, Justin N Williams, Tarun Puri, Jian Li, Minji K Uh, Boris K Lin, Caicun Zhou
CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced Non-Small Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (21) (2024)
Maurice Pérol, Benjamin J Solomon, Koichi Goto, Keunchil Park, Ernest Nadal, Emilio Bria, Claudio Marcelo Martin, Jair Bar, Justin N Williams, Tarun Puri, Jian Li, Minji K Uh, Boris K Lin, Caicun Zhou
CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced Non-Small Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (21) (2024)
Maurice Pérol, Benjamin J Solomon, Koichi Goto, Keunchil Park, Ernest Nadal, Emilio Bria, Claudio Marcelo Martin, Jair Bar, Justin N Williams, Tarun Puri, Jian Li, Minji K Uh, Boris K Lin, Caicun Zhou
CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced Non-Small Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Caicun Zhou, Minu K Srivastava, Hao Xu, Enriqueta Felip, Heather Wakelee, Nasser Altorki, Martin Reck, Rüdiger Liersch, Anna Kryzhanivska, Satoshi Oizumi, Hiroshi Tanaka, John Hamm, Steven L McCune, Elizabeth Bennett, Barbara Gitlitz, Virginia McNally, Marcus Ballinger, Mark McCleland, Wei Zou, Meghna Das Thakur, Silvia Novello
Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trial. Journal for immunotherapy of cancer 11 (10) (2023)
Caicun Zhou, Haoyue Guo, Xiaolong Zhou, Huikang Xie, Tian Tian, Wencheng Zhao, Guanghui Gao, Anwen Xiong, Lei Wang, Wei Li, Xiaoxia Chen, Yan Zhang, Jue Fan, Fengying Wu, Yongchang Zhang, Caicun Zhou
Immune checkpoint inhibitors plus chemotherapy in patients with locally advanced or metastatic pulmonary sarcomatoid carcinoma: a multicentric real-world study. Therapeutic advances in medical oncology 14 (2022)
Yaokai Wen, Tao Jiang, Xiangrong Wu, Haoxin Peng, Shengxiang Ren, Caicun Zhou
Front-line treatment for advanced non-small-cell lung cancer and ALK fusion: a network meta-analysis. Therapeutic advances in medical oncology 14 (2022)
Tao Jiang, Jianhua Chen, Xingxiang Xu, Ying Cheng, Gongyan Chen, Yueyin Pan, Yong Fang, Qiming Wang, Yunchao Huang, Wenxiu Yao, Rui Wang, Xingya Li, Wei Zhang, Yanjun Zhang, Sheng Hu, Renhua Guo, Jianhua Shi, Zhiwu Wang, Peiguo Cao, Donglin Wang, Jian Fang, Hui Luo, Yi Geng, Chunyan Xing, Dongqing Lv, Yiping Zhang, Junyan Yu, Shundong Cang, Yaxi Zhang, Jiao Zhang, Zeyu Yang, Wei Shi, Jianjun Zou, Caicun Zhou, Shengxiang Ren
On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial. Molecular cancer 21 (1) (2022)
Fengying Wu, Tao Jiang, Gongyan Chen, Yunchao Huang, Jianying Zhou, Lizhu Lin, Jifeng Feng, Zhehai Wang, Yongqian Shu, Jianhua Shi, Yi Hu, Qiming Wang, Ying Cheng, Jianhua Chen, Xiaoyan Lin, Yongsheng Wang, Jianan Huang, Jiuwei Cui, Lejie Cao, Yunpeng Liu, Yiping Zhang, Yueyin Pan, Jun Zhao, LiPing Wang, Jianhua Chang, Qun Chen, Xiu-Bao Ren, Wei Zhang, Yun Fan, Zhiyong He, Jian Fang, Kangsheng Gu, Xiaorong Dong, Tao Zhang, Wei Shi, Jianjun Zou, Xuejuan Bai, Shengxiang Ren, Caicun Zhou, null null
Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non-small-cell lung cancer characterizes the features of response to PD-1 blockade plus chemotherapy. Cancer communications (London, England) (2022)
Tao Jiang, Yan Yan, Kun Zhou, Chunxia Su, Shengxiang Ren, Nan Li, Likun Hou, Xianchao Guo, Wei Zhu, Henghui Zhang, Jie Lin, Jun Zhang, Caicun Zhou
Characterization of evolution trajectory and immune profiling of brain metastasis in lung adenocarcinoma. NPJ precision oncology 5 (1) (2021)
Tao Jiang, Pingyang Wang, Jie Zhang, Yanqiu Zhao, Jianying Zhou, Yun Fan, Yongqian Shu, Xiaoqing Liu, Helong Zhang, Jianxing He, Guanghui Gao, Xiaoqian Mu, Zhang Bao, Yanjun Xu, Renhua Guo, Hong Wang, Lin Deng, Ningqiang Ma, Yalei Zhang, Hui Feng, Sheng Yao, Jiarui Wu, Luonan Chen, Caicun Zhou, Shengxiang Ren
Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trial. Signal transduction and targeted therapy 6 (1) (2021)
Tao Jiang, Qingzhu Jia, Wenfeng Fang, Shengxiang Ren, Xiaoxia Chen, Chunxia Su, Li Zhang, Caicun Zhou
Pan-cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment. Clinical and translational medicine 10 (2) (2020)
Tao Jiang, Tao Shi, Henghui Zhang, Jie Hu, Yuanlin Song, Jia Wei, Shengxiang Ren, Caicun Zhou
Tumor neoantigens: from basic research to clinical applications. Journal of hematology & oncology 12 (1) (2019)
Tao Jiang, Qian Chu, Huijuan Wang, Fei Zhou, Guanghui Gao, Xiaoxia Chen, Xuefei Li, Chao Zhao, Qinghua Xu, Wei Li, Fengying Wu, Anwen Xiong, Jing Zhao, Yaping Xu, Chunxia Su, Shengxiang Ren, Caicun Zhou, Fred R Hirsch
EGFR-TKIs plus local therapy demonstrated survival benefit than EGFR-TKIs alone in EGFR-mutant NSCLC patients with oligometastatic or oligoprogressive liver metastases. International journal of cancer 144 (10) (2018)
Tao Jiang, Meng Qiao, Chao Zhao, Xuefei Li, Guanghui Gao, Chunxia Su, Shengxiang Ren, Caicun Zhou
Pretreatment neutrophil-to-lymphocyte ratio is associated with outcome of advanced-stage cancer patients treated with immunotherapy: a meta-analysis. Cancer immunology, immunotherapy : CII 67 (5) (2018)